Oncology Pharma Inc. (ONPH)

Market Cap	398.23K +10,200.9%
Revenue (ttm)	10.21K -98.4%
Net Income	186.04K
EPS	n/a
Shares Out	38.66M
PE Ratio	2.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	911
Average Volume	2,290
Open	0.0102
Previous Close	0.0100
Day's Range	0.0102 - 0.0103
52-Week Range	n/a
Beta	-4.75
RSI	68.17
Earnings Date	n/a

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONPH

Financial Performance

In fiscal year 2013, Oncology Pharma's revenue was $10,214, a decrease of -92.42% compared to the previous year's $134,700. Earnings were $186,035, an increase of 216.79%.